Capital Fund Management (CFM)
NBP

Capital Fund Management (CFM)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Capital Fund Management (CFM)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62,492
Closed -$706K – 1531
2022
Q2 		$706K Sell
62,492
-66,355
-51% -$795K 0.01% 1171
2022
Q1 		$2.09M Buy
128,847
+107,383
+500% +$2.75M 0.02% 934
2021
Q4 		$1.02M Buy
+21,464
New +$1.29M 0.01% 1274

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Fund Management (CFM)'s NBP Position: Q3 2022 in Review

Capital Fund Management (CFM) sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 62,492 shares — an estimated $706K sold.

Capital Fund Management (CFM) first reported a position in NBP in Q4 2021 and held it in 3 quarters. The position peaked at $2.09M in Q1 2022. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Capital Fund Management (CFM) reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 62,492 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $706K.
  • Capital Fund Management (CFM) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Capital Fund Management (CFM)'s NovaBridge Biosciences American Depositary Shares position peaked at $2.09M in Q1 2022.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2022, filed 14 Nov 2022.